Neurology 2003;61:160-164
© 2003 American Academy of Neurology
Analgesic use: A predictor of chronic pain and medication overuse headache
The Head–HUNT Study
J.-A. Zwart, MD PhD,
G. Dyb, MD,
K. Hagen, MD PhD,
S. Svebak, PhD and
J. Holmen, MD PhD
From the Department of Clinical Neuroscience (Drs. Zwart and Hagen), Section of Neurology, Department of Psychiatry and Behavioural Medicine (Drs. Dyb and Svebak), and HUNT Research Centre (Dr. Holmen), Faculty of Medicine, Norwegian University of Science and Technology, Trondheim.
Address correspondence and reprint requests to Dr. J.-A. Zwart, Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, 7006 Trondheim, Norway; e-mail: john-anker.zwart{at}medisin.ntnu.no
Objective: To examine the relation between analgesic use at baseline and the subsequent risk of chronic pain ( 15 days/month) and the risk of analgesic overuse.
Methods: In total, 32, 067 adults reported the use of analgesics in 1984 to 1986 and at follow-up 11 years later (1995 to 1997). The risk ratios (RR) of chronic pain and RR of analgesic overuse in the different diagnostic groups (i.e., migraine, nonmigrainous headache, neck pain, and low-back pain) were estimated in relation to analgesic consumption at baseline.
Results: Individuals who reported use of analgesics daily or weekly at baseline showed significant increased risk for having chronic pain at follow-up. The risk was most evident for chronic migraine (RR = 13.3, 95% CI: 9.3 to 19.1), intermediate for chronic nonmigrainous headaches (RR = 6.2, 95% CI: 5.0 to 7.7), and lowest for chronic neck (RR = 2.4, 95% CI: 2.0 to 2.8) or chronic low-back (RR = 2.3, 95% CI: 2.0 to 2.8) pain. Among subjects with chronic pain associated with analgesic overuse, the RR was 37.6 (95% CI: 21.3 to 66.4) for chronic migraine, 14.4 (95% CI: 10.4 to 19.9) for chronic nonmigrainous headaches, 7.1 for chronic neck pain (95% CI: 5.5 to 9.2), and 6.4 for chronic low-back pain (95% CI: 4.9 to 8.4). The RR for chronic headache (migraine and nonmigrainous headache combined) associated with analgesic overuse was 19.6 (95% CI: 14.8 to 25.9) compared with 3.1 (95% CI: 2.4 to 4.2) for those without overuse.
Conclusion: Overuse of analgesics strongly predicts chronic pain and chronic pain associated with analgesic overuse 11 years later, especially among those with chronic migraine.
This article has been cited by other articles:
|
|
|
|
 
A. Scher, R. Lipton, W. Stewart, and M Bigal
Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study
Cephalalgia,
March 1, 2010;
30(3):
321 - 328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M D. Felice and F Porreca
Opiate-Induced Persistent Pronociceptive Trigeminal Neural Adaptations: Potential Relevance to Opiate-Induced Medication Overuse Headache
Cephalalgia,
December 1, 2009;
29(12):
1277 - 1284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Katsarava, A. Dzagnidze, M. Kukava, E. Mirvelashvili, M. Djibuti, M. Janelidze, R. Jensen, L. J. Stovner, T. J. Steiner, and On behalf of Lifting The Burden: The Global Campai
Primary headache disorders in the Republic of Georgia: Prevalence and risk factors
Neurology,
November 24, 2009;
73(21):
1796 - 1803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Jensen and L Bendtsen
Medication Overuse Headache in Scandinavia
Cephalalgia,
November 1, 2008;
28(11):
1237 - 1239.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Rueda-Sanchez and L. Diaz-Martinez
Prevalence and Associated Factors for Episodic and Chronic Daily Headache in the Colombian Population
Cephalalgia,
March 1, 2008;
28(3):
216 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Aamodt, L. Stovner, K Hagen, and J-A Zwart
Comorbidity of Headache and Gastrointestinal Complaints. The Head-HUNT Study
Cephalalgia,
February 1, 2008;
28(2):
144 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Pageler, Z Katsarava, H. Diener, and V Limmroth
Prednisone vs. Placebo in Withdrawal Therapy Following Medication Overuse Headache
Cephalalgia,
February 1, 2008;
28(2):
152 - 156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H-C Diener, G Bussone, J. V. Oene, M Lahaye, S Schwalen, P. Goadsby, and on behalf of the TOPMAT-MIG-201(TOP-CHROME) Study
Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Cephalalgia,
July 1, 2007;
27(7):
814 - 823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Hagen, L. Stovner, and J-A Zwart
Potentials and Pitfalls in Analytical Headache Epidemiological Studies--Lessons to be Learned from the Head-HUNT Study
Cephalalgia,
May 1, 2007;
27(5):
403 - 413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Stovner, K Hagen, R Jensen, Z Katsarava, R. Lipton, A. Scher, T. Steiner, and J-A Zwart
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
Cephalalgia,
March 1, 2007;
27(3):
193 - 210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Paemeleire, A. Bahra, S. Evers, M. S. Matharu, and P. J. Goadsby
Medication-overuse headache in patients with cluster headache.
Neurology,
July 11, 2006;
67(1):
109 - 113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Gupta
Orbitofrontal cortex hypometabolism, medication overuse headache, substance abuse and migraine: key pathophysiological issues.
Brain,
July 1, 2006;
129(Pt 7):
E52 - E52.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fumal, R. Kupers, and J. Schoenen
Reply: Orbitofrontal cortex hypometabolism, medication overuse headache, substance abuse and migraine: key pathophysiological issues
Brain,
July 1, 2006;
129(7):
E53 - E53.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Laimi, L Metsahonkala, P Anttila, M Aromaa, T Vahlberg, J. Salminen, and M Sillanpaa
Outcome of Headache Frequency in Adolescence
Cephalalgia,
May 1, 2006;
26(5):
604 - 612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Dyb, T. L. Holmen, and J.-A. Zwart
Analgesic overuse among adolescents with headache: The Head-HUNT-Youth Study
Neurology,
January 24, 2006;
66(2):
198 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Dodick
Chronic Daily Headache
N. Engl. J. Med.,
January 12, 2006;
354(2):
158 - 165.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Millichap
Medication Overuse Worsens Chronic Daily Headache
AAP Grand Rounds,
November 1, 2005;
14(5):
55 - 55.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. -A. Zwart, G. Dyb, K. Hagen, S. Svebak, L. J. Stovner, and J. Holmen
Analgesic overuse among subjects with headache, neck, and low-back pain
Neurology,
May 11, 2004;
62(9):
1540 - 1544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Whitall
Stroke Rehabilitation Research: Time to Answer more Specific Questions?
Neurorehabil Neural Repair,
March 1, 2004;
18(1):
3 - 8.
[PDF]
|
|
|
|
|
|
|
F. D. Sheftell, S. J. Tepper, A. M. Rapoport, J.-A. Zwart, G. Dyb, K. Hagen, S. Svebak, and J. Holmen
Analgesic use: A predictor of chronic pain in medication overuse headache: The Head-HUNT Study
Neurology,
February 24, 2004;
62(4):
677 - 677.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. B. Lipton and M. E. Bigal
Chronic daily headache: Is analgesic overuse a cause or a consequence?
Neurology,
July 22, 2003;
61(2):
154 - 155.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Dyb, T. L. Holmen, and J.-A. Zwart
Analgesic overuse among adolescents with headache: The Head-HUNT-Youth Study
Neurology,
January 24, 2006;
66(2):
198 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
Correspondence:
Read all Correspondence
- Analgesic use: a predictor of chronic pain in medication overuse headache.
- Fred D Sheftell, et al.
- Neurology Online, 6 Aug 2003
[Full text]
- Analgesic use: A predictor of chronic pain and medication overuse headache: The Head–HUNT Study
- John-Anker Zwart, et al.
- Neurology Online, 6 Aug 2003
[Full text]
|
